================================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
For Registration of Certain Classes of Securities
Pursuant to Section 12(b) or (g) of the
Securities Exchange Act of 1934
MEDITRUST CORPORATION
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 95-3520818
- ---------------------------------------- ------------------------------------
(State of incorporation or organization) (I.R.S. Employer Identification No.)
197 First Avenue, Suite 300
Needham, Massachusetts 02194
----------------------------------------------------
(Address of principal executive offices and Zip Code)
Securities to be registered pursuant to Section 12(b) of the Act:
Title of each class Name of each exchange
to be so registered on which each class is
- ------------------- to be registered
9% Series A Cumulative Redeemable Preferred -----------------------
Stock (the "Preferred Stock"), represented by New York Stock Exchange
depositary shares, each of which represents
1/10 of a share of Preferred Stock (the
"Depositary Shares")
If the Form relates to the registration of a class of securities
pursuant to Section 12(b) of the Exchange Act and is effective pursuant to
General Instruction A.(c), check the following box. [X]
If this Form relates to the registration of a class of securities
pursuant to Section 12(g) of the Exchange Act and is effective pursuant to
General Instruction A.(d), check the following box. [ ]
Securities to be registered pursuant to Section 12(g) of the Act:
None
(Title of Class)
================================================================================
<PAGE>
Item 1. Description of Registrant's Securities to be Registered
The description of the Preferred Stock and the Depositary Shares is
incorporated by reference to the Joint Registration Statement on Form S-3 of
Meditrust Corporation and Meditrust Operating Company (File Nos. 40055 and
40055-1) as supplemented by the Prospectus Supplement filed pursuant to Rule
424(b).
Item 2. Exhibits
All exhibits required by the Instructions to Item 2 will be supplied to
the New York Stock Exchange.
<PAGE>
Pursuant to the requirements of Section 12 of the Securities Exchange
Act of 1934, the Registrant has duly caused this registration statement to be
signed on its behalf by the undersigned, thereto duly authorized.
MEDITRUST CORPORATION
Date: June 10, 1998
----------------------------------
By: /s/ Michael S. Benjamin
-----------------------------------
Michael S. Benjamin
Senior Vice President
